Montara Therapeutics

San Francisco, CA · Founded 2023 · Privately Held (backing)

Operator of a biopharmaceutical company intended to enhance the safety and efficacy of treatments for neurological diseases. Montara Therapeutics is based in San Francisco, CA and was founded in 2023. It was valued at $55 million at its seed round in Feb 2025, the last priced event on record. It has raised $28 million across 2 recorded rounds; the latest was a $20 million early-stage round in Feb 2025.

PMV mark · valuation
$55.0M
Oct 2026
Priced at
its seed round
Feb 2025
Total raised
$28.0M
Last round
Early Stage VC
Feb 2025

Who backs Montara Therapeutics?

8 investors
InvestorType
Dolby Family VenturesVenture capital
SV Health InvestorsVenture capital
Bayshore Global ManagementFamily office
BEVC (Berkeley)—
KdT Ventures—
Michael J. Fox Foundation—
Troy Wilson—
Two Bear Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Montara Therapeutics investors

8 investors are on record for Montara Therapeutics, including Dolby Family Ventures, SV Health Investors, Bayshore Global Management and BEVC (Berkeley). The early-stage round in Feb 2025 drew 9 investors.

Free account
More of Montara Therapeutics with a free account
  • ·Watch Montara Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Montara Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View